Click Therapeutics

New York, NY · United States

Digital Health & DTxmid

Specialization: Prescription digital therapeutics

Key Differentiator

Co-develops FDA-cleared software treatments with pharma partners, such as Rejoyn with Otsuka.

Core Services

Prescription digital therapeutics; Software-enhanced drugs (Click SE); Clinical validation of software treatments; Pharma co-development

Capabilities

Mobile app based treatmentsSoftware paired with drug therapyClinical trials of digital therapeuticsRegulatory clearance of software as a medical device

Market Intelligence

Partners include Otsuka (CT-152, Rejoyn) and Boehringer Ingelheim (CT-155 and CT-156). Investors named on its site include HIG, Accelmed and Sanofi Ventures.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.